Synthesis and Biologic Evaluation of an Iodine-Labeled Entecavir Derivative for Anti-hepatitis B Virus Activity
ConclusionsThe study outcome establishes125I-ETV as a candidate for anti-HBV. However, it is still in need of further endorsement and optimization by animal model studies before using125I-ETV to treat chronic HBV disease.
Source: Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Chemistry | Hepatitis | Hepatitis B | Iodine | Liver | Molecular Biology | Nuclear Medicine | Study | Urology & Nephrology